To study the effect of parecoxib sodium (PS) application, combined with enhanced recovery after surgery (ERAS) nursing, on inflammation and knee joint function in elderly patients after total knee arthroplasty (TKA)
To compare the effects of parecoxib sodium, an injectable prodrug of a cyclo-oxygenase-2—specific inhibitor, and ketorolac on platelet function and bleeding time in elderly individuals and non-elderly adults
The purposes of this study were to investigate the efficacy of parecoxib on postoperative inflammatory response, and to assess serum levels of acute phase reactants, for example cytokine (IL)-6 and C-reactive protein (CRP) in patients who have undergone percutaneous nephrolithotomy (PCNL)
The purpose of this study was to compare the analgesic activity of 2 doses of parecoxib sodium, ketorolac, and morphine with placebo after gynecologic surgery that requires laparotomy.
The gastrointestinal safety of the novel injectable cyclooxygenase-2 selective inhibitor, parecoxib sodium, was compared with the nonselective nonsteroidal anti-inflammatory drug, ketorolac, and placebo in healthy subjects.